Bank Of New York Mellon Corp Cocrystal Pharma, Inc. Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	BUY	$0.48 - $0.71 $0 - $0	1 Added 0.0%	44,523 $24,000
Q1 2021 May 13, 2021	SELL	$1.3 - $2.35 $6,271 - $11,336	-4,824 Reduced 9.78%	44,522 $61,000
Q4 2020 Feb 09, 2021	BUY	$0.8 - $2.16 $39,476 - $106,587	49,346 New	49,346 $67,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.